Members

Green, Shulamite A.

Research

Functional neuroimaging, psychophysiology, and behavioral observation to understand sensory processing differences among children particularly at risk (e.g., autism, ADHD, early life stress, prenatal drug exposure)

Appointments

  • Assistant Professor

Biography

Dr. Green’s current research combines functional neuroimaging, psychophysiology, and behavioral observation to understand sensory processing differences among children particularly at risk (e.g., autism, ADHD, early life stress, prenatal drug exposure). Research goals include 1) identify the neurobiological and physiological mechanisms underlying sensory processing difficulties; 2) determine whether these mechanisms are shared or distinct across risk groups; 3) examine how sensory processing affects higher-level cognition such as attention, social functioning, and executive functioning; and 4) use this information to inform identification and treatment of children at high risk for sensory processing difficulties.

Publications

  1. Green, SA. Art in Science: Horus Has Been Bitten. Clin Orthop Relat Res. 2026;484 (11):2121-2124. doi: 10.1097/CORR.0000000000004131. PubMed PMID:42766293 .
  2. Cakar, ME, Cummings, KK, Bookheimer, SY, Dapretto, M, Green, SA. Atypical Cerebellar Responses are Associated with Altered Neural Habituation during Sensory Stimulation in Autism. Autism Res. 2026;19 (10):e70313. doi: 10.1002/aur.70313. PubMed PMID:42657904 PubMed Central PMC13644733.
  3. Green, SA. Art in Science: Why Two Leicas?. Clin Orthop Relat Res. 2026;484 (9):1690-1692. doi: 10.1097/CORR.0000000000004074. PubMed PMID:42463126 .
  4. Shah, UT, Evans, K, Banchik, M, Chaturvedi, A, Ramappa, S, Wong, K et al.. Cognitive reappraisal modulates neural responses to aversive sensory stimulation in autistic youth. J Child Psychol Psychiatry. 2026; :. doi: 10.1111/jcpp.70202. PubMed PMID:42454526 PubMed Central PMC13644732.
  5. Leahey, RR, Weber, M, Cho, CH, Hur, SK, Cramer, A, Manzanares, K et al.. Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegeneration. NPJ Drug Discov. 2025;2 (1):. doi: 10.1038/s44386-025-00023-4. PubMed PMID:42380237 PubMed Central PMC13267063.
Search PubMed